Speakers Mureen Allen, MD, MS, MA, FACP, and Jill Pritts, will discuss data curation strategies that can help payers achieve their Quadruple Aim goals of improved clinician experience, improved patient experience, better outcomes, and lower costs.

TULSA, Okla. (PRWEB)
June 21, 2022

The US healthcare system produces some of the best health outcomes in the world, but the quality of care is inconsistent. To improve patient care, CMS has mandated several quality measurement initiatives including Star ratings and NCQA HEDIS measures. But the reporting requirements for these programs can be exceptionally resource-intensive — and the consequences of lower quality scores can be dramatic for payer organizations and their members.

So, what’s a payer to do?

Expert leadership at Verinovum — a powerhouse in curating high-quality healthcare data — will join with Envision Health to present the webinar “Simplifying Your Quality-of-Care Equation with Usable Clinical Data” on Tuesday, June 28, from 1-1:45 p.m. EDT.

Centering the discussion around balancing quality protocols with resource-intensive reporting processes, webinar hosts will examine how health plans can utilize a combination of clinical data curation and analytic tools to better understand their members’ health needs and, ultimately, improve care and outcomes.

Verinovum Chief Medical Information Officer Mureen Allen, MD, MS, MA, FACP, and Envision Health Senior Technical Writer, Jill Pritts, will discuss data curation strategies that can help payers achieve the Quadruple Aim’s goals of improved clinician experience, improved patient experience, better outcomes, and lower costs.

They will answer questions like:

• How are evolving strategies and policies around interoperability being implemented to improve clinical data aggregation and sharing?
• How does clinical data quality impact the quality-of-care equation?
• What are the data challenges around improving contracting and value-based care, and how can you solve them?
• What kind of impact can timely care and disease management intervention have on your membership?
• What can organizations do now to advance their quest to achieve the Quadruple Aim?

About the speakers

Verinovum’s Chief Medical Information Officer Mureen Allen, MD, FACP, oversees the design, implementation, and roadmap of the organization’s technology and provides guidance and support to the company’s clinical team. Throughout her career, Dr. Allen has demonstrated market-leading expertise in medical informatics, strategic planning, and analytics in executive roles with Fortune 500 payer organizations. Prior to working at Verinovum, Dr. Allen served as the Senior Vice President at UnitedHealthcare, where she was responsible for clinical data management and analytics solutions. She is a fellow of the American College of Physicians, the American Medical Association, and the American Medical Informatics Association. She is board-certified in Internal Medicine and Clinical Informatics.

Jill Pritts, Senior Technical Writer at Envision Health has 25 years of experience in the healthcare and life sciences industries. For 17 years, she held various roles at IBM Watson Health, where she focused on healthcare communications, market intelligence, and industry stakeholder strategy. With a broad understanding of the political, economic, and societal pressures transforming how healthcare is administered and paid for, she has a passion for helping the industry shift to one predicated on value. She has worked as a physiology instructor at Eastern Michigan University and a competitive intelligence professional for Pfizer and holds a Master of Science in Physiology from the University of Michigan.

Please REGISTER HERE for this free event. The webinar will also be available on-demand shortly after the event.

About Verinovum

Verinovum provides data curation and enrichment solutions that help organizations improve operating performance. Verinovum delivers clean, complete, and accurate data, supporting healthcare organizations in accessing the right information, in the right format, at the right time, to fulfill specific use cases and achieve clinical and business goals. Discover more at Verinovum.com.

About Envision Health

Envision Health is an award-winning marketing, public relations, and consulting partner for businesses in healthcare and healthcare technology. Founded by two industry experts with 50+ years of combined healthcare experience, we believe the convergence of clinical insight and marketing and PR expertise is the key to transforming healthcare communications. We are “clinically informed” — this means that everything we do is backed by deep healthcare expertise and first-hand knowledge of the landscape our customers operate in. Our services encompass everything from marketing strategies and tactics to company rebrands, to media relations. Envision’s clinical and marketing experts ensure every marketing and public relations deliverable is strategically aligned, clinically informed, and creatively inspired.

Share article on social media or email:

“Our collaboration with Alcoholism and Substance Abuse Providers of New York State is inspiring. We are certain that our partnership will result in long-term growth and the opportunity to provide services that benefit the communities we both serve,” said Alan Tillinghast, CEO of Cantata

AUSTIN, Texas (PRWEB)
June 21, 2022

Cantata Health Solutions, a leading provider of healthcare technology solutions for the Behavioral Health industry, has announced that they have entered into an affiliate partnership with the New York Association of Substance Abuse Providers (NYASAP). The goal of this partnership is to better serve the communities that both organizations are a part of.

The affiliation will allow for collaboration between the two groups in order to provide training, education, and resources on substance abuse prevention and treatment. In addition, it will also give NYASAP members special discounts towards access to Cantata’s technology solutions and services. This new partnership is just one example of how Cantata is working to improve the quality of care for those affected by substance abuse.

ASAP’s mission is to support organizations, groups, and individuals that prevent and alleviate the profound personal, social, and economic consequences of alcohol and substance use disorders in New York State.

Lou Desso, CASAC, Alcoholism & Substance Abuse Providers, said, “We are excited to enter into an affiliate partnership with Cantata Health Solutions. I believe it’s the strong match between our similar beliefs in terms of goals for service delivery as well as mutual trust which will allow us both better access & representation within respective communities.”

ASAP offers a variety of educational activities and state-of-the-art resources to strengthen treatment and prevention efforts in New York, and provides valuable information to people interested in problem gambling and chemical dependence.

“Our collaboration with Alcoholism and Substance Abuse Providers of New York State is inspiring. We are certain that our partnership will result in long-term growth and the opportunity to provide services that benefit the communities we both serve,” said Alan Tillinghast, CEO of Cantata Health Solutions, Garden City, NY

Cantata’s mission is to revolutionize solutions that support the delivery of person-centered care through innovation, compassion, and collaboration. Cantata is a true partner in helping organizations focus on their objective of improving people’s lives by assisting them in providing care for their communities.

About Alcoholism and Substance Abuse Providers of New York State (ASAP)

The Alcoholism and Substance Abuse Providers of New York State (ASAP) is committed to working together to support organizations, groups, and individuals that prevent and alleviate the profound personal, social, and economic consequences of alcoholism and substance abuse in New York State. ASAP represents the interests of the largest alcoholism and substance abuse prevention, treatment, research, and training providers in the country. We also welcome membership from coalitions, businesses, organizations, and individuals who support ASAP’s mission.

Prevention program members include both school and community-based programs. Treatment program members include out-patient treatment, hospital-based in-patient, and community based residential rehab, methadone treatment, meth withdrawal treatment, and vocational/educational service providers working in collaboration with treatment programs. Research and training members include universities, research institutes, and training organizations. The members of ASAP govern Association affairs through a Board of Directors and its structure of task forces and committees. An Executive Committee is nominated and elected by the membership for a two-year term. For more information about NYASAP, visit: https://www.asapnys.org/

About Cantata Health Solutions

Cantata Health Solutions delivers award-winning software purpose-built to improve the health of acute, post-acute, and behavioral health facilities and their patients. Cantata Health’s Revenue Cycle Management (RCM), financial management, and Electronic Health Record (EHR) software are highly configurable to meet the unique needs of each facility or system, providing staff and administrators with greater visibility of patient care across the continuum of care, ensuring predictable financial outcomes, improving back-office operations and clinical efficiency, and enhancing revenue recovery. Headquartered in Austin, Texas, their team of experts provides uncommonly attentive service and support. For more information about Cantata Health Solutions and Arize EHR, visit: https://cantatahealth.com

Share article on social media or email:

North Texas Orthopedics & Spine Center Offers Interventional & Advanced Spine Care in Grapevine/Fort Worth

At North Texas Orthopedics & Spine Center, we believe in giving people the best possible options for their unique concerns . . . Intracept is a small procedure that can provide a big impact on improving lifestyle and function.

FORT WORTH, Texas (PRWEB)
June 20, 2022

The breakthrough back procedure that is making the news and is now helping TODAY host Carson Daly also helps many Dallas/Forth Worth community members through the team at North Texas Orthopedics & Spine Center.

Highlights of the novel procedure, Intracept by Relievant, include:

• 
  Same-day, minimally invasive procedure with a quick recovery that treats pain at the source.
• Offers long-term pain reduction and function improvement shown five years post-procedure.*
• Decreases opioid use and pain injection use long-term.*
• Very high patient satisfaction rate.*

“At North Texas Orthopedics & Spine Center, we believe in giving people the best possible options for their unique concerns, which includes leading-edge techniques like Intracept,” says fellowship-trained and double-board-certified as an interventional spine and pain physician, Dr. Melissa Murphy. “Low back pain is a common and growing problem, and Intracept is a small procedure that can provide a big impact on improving lifestyle and function.”

Find out more about Intracept and back pain care options available in the Dallas/Forth Worth area by visiting with a specialist at North Texas Orthopedics & Spine Center. Patients in need of spine and pain-related care can call (817) 481-2121 for an appointment or visit http://www.ntxortho.com to learn more.

*Fischgrund J, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-34. doi.org/10.1007/s00586-020-06448-x

Share article on social media or email:

“When our facility decided to change pharmacy services to UnitedRx, it was due to their ability to offer a wide variety of products for my residents at the most cost-effective rates,” said Gem City Healthcare & Rehabilitation Center Director of Nursing Ken Chapman.

HILLSIDE, Ill. (PRWEB)
June 20, 2022

As prices continue to rise in the U.S. across all markets, many nursing facilities and residents are feeling the pressure of escalating prescription drug costs. High pricing remains a major obstacle for many facilities that no longer have the bandwidth to accommodate patients requiring critical medicine. UnitedRx, the Midwest’s largest full-service, independent long-term care pharmacy, is utilizing its impressive buying power to provide long-term care facilities with typically expensive drugs at a more affordable price point.

“Prescription drug costs continue to rise with no sign of slowing down, placing a lot of stress on nursing facilities that accommodate residents who require expensive medications,” said UnitedRx Chief Executive Officer Chuck Benain. “We understand that there are limited dollars for new admissions, and we are always looking for ways for facilities to reduce the drug spend on those admissions.”

Employing over 20 suppliers to find the best offers from multiple manufacturers, UnitedRx secures highly demanded prescriptions at a comparatively lower price point. The pharmacy uses multiple techniques to save facilities money on their drug spending, continuously working to provide a transparent model that proves effective time and time again.

“Facing the challenges of maintaining a superior competitive clinical program in Post-Acute Care requires superior clinical partners,” said Gem City Healthcare & Rehabilitation Center Director of Nursing Ken Chapman. “When our facility decided to change pharmacy services to UnitedRx, it was due to their ability to offer a wide variety of products for my residents at the most cost-effective rates. I have saved several thousand dollars a month while offering a superior clinical service associated with the now availability of normally high-cost medications for reasonable rates. This has allowed my facility to expand the ability to accept referrals that would otherwise be denied given the costs in servicing their clinical plan of care. On top of the savings benefits I have direct access to speak to the team in getting my needs met in every capacity. As a DON with 26 years experience in Post-Acute Care, I have never had a more dedicated pharmacy partner.”

Through its unique pricing strategies, UnitedRx offers prescription drugs that are notoriously expensive such as Insulins as well as inhalers, and over the counter (OTC) medications. Daptomycin, for example, is an antibiotic used to treat complex skin and tissue infections and normally has a market value of $1,490.36 at full price.

“This antibiotic, like so many others, is extremely expensive,” said UnitedRx National Director of Sales and Marketing Melanie Williams. “With our buying power, we are able to offer this medication at 1/10th of the normal market rate. Making highly demanded prescriptions such as Daptomycin more accessible, really opens doors for more admissions in nursing homes.”

Based in Illinois, UnitedRx currently provides services to over 350 facilities across 20 states, totaling more than 36,000 beds at skilled nursing facilities, assisted living communities, group homes, intermediate care facilities (ICF-DD), and hospice. Priding itself on providing a friendly neighborhood pharmacy experience, the organization pledges to exceed all expectations with state-of-the-art communication and packaging technologies, as well as custom and flexible solutions to address specific customer needs and centralized billing.

About UnitedRx

UnitedRx is one of the largest, full-service, independent long-term care pharmacies headquartered in Illinois. Developed in 2008, UnitedRx has grown to over 350 facilities consisting of skilled nursing facilities, assisted living communities, youth homes, intermediate care facilities (ICF-DD), and hospice care. UnitedRx serves over 36,000 beds across 20 states with pharmacy locations in Illinois, Pennsylvania, Kansas, Nevada, and Tennessee, while employing over 350 people with an average of seven years of experience in the pharmaceutical industry. UnitedRx is committed to performing outstanding customer service to form meaningful and long-lasting relationships to produce positive results with facilities they partner with. For more information, visit https://www.unitedrx.net.

Share article on social media or email:

KAMUT® Khorasan Wheat

“These promising results are a step towards identifying more effective treatments that can help improve quality of life for people suffering with fibromyalgia,” Trevor Blyth, President of Kamut International.

MISSOULA, Mont. (PRWEB)
June 20, 2022

A recent study conducted by the University of Florence Department of Experimental and Clinical Medicine in Italy, and published in the World Journal of Gastroenterology (WJG), indicated benefits of a dietary treatment when applied to the clinical care of patients with fibromyalgia. Aligned with recent guidelines suggesting that an optimal strategy to treat fibromyalgia includes a combination of pharmacological and non-pharmacological treatment, in results of this study participants that underwent a substitute diet with ancient KAMUT® khorasan wheat reported significant improvement in widespread pain, quality of sleep, and impact of the disease. Moreover, a KAMUT® khorasan wheat-based diet resulted in beneficial gut microbiota composition and functional modifications as well as improvement in reported symptoms.

“These promising results are a step towards identifying more effective treatments that can help improve quality of life for people suffering with fibromyalgia,” says Trevor Blyth, President of Kamut International. “We are committed to continuing investigations with the goal of helping to identify and explain the benefits of combating chronic health problems through good and healthy food.”

The first article from this study published in Pain Medicine(i) reported a significant improvement in the reported fibromyalgia (FM) severity scores (Widespread Pain Index (WPI) + Severity Scale (SS)) and in the Functional Outcome of Sleep scores (FOSQ), which decreased significantly by 21.5% and 11.7% respectively only after the KAMUT® khorasan diet period, while no statistically significant variations were reported after the control diet period. Similarly, the FM Impact scores (FIQ) decreased significantly only after the KAMUT® khorasan diet period, with a reduction that was significantly different between the intervention and control diet periods (– 22.5% vs. – 0.3%, respectively).

A second article derived from the same study and just published in World Journal of Gastroenterology(ii) reported a positive effect of a KAMUT® khorasan wheat-based diet on gut microbiota composition and on both the intestinal inflammatory and SCFA (Short Chain Fatty Acid) profiles, with an increase of butyric acid which is known to exert anti-inflammatory effects as well as analgesic and antidepressant effects.

Fibromyalgia is a medical condition estimated to affect 2-8% of the general population, with a higher frequency in women. Fibromyalgia is characterized by chronic widespread pain accompanied by multiple somatic and psychological manifestations. Symptoms may include abnormal pain or function in the bowel or bladder, excessive fatigue and tiredness, stiff joints, poor sleep, and even neurological problems.

This is the fifth in a series of human studies on non-infectious chronic diseases comparing the effects of diets based on ancient KAMUT® wheat to diets based on modern wheat. Previous studies in this series were conducted with participants suffering from Irritable Bowel Syndrome, Acute Coronary Syndrome, Diabetes Mellitus Type 2, Non-Alcoholic Fatty Liver Disease, and to investigate KAMUT® wheat compared to modern wheat based on measurement of biochemical, antioxidant, and anti-inflammatory markers.

About KAMUT® Brand Khorasan Wheat

From 36 kernels and a 70 year old legend of discovery in an Egyptian tomb, today KAMUT® Brand khorasan wheat, an ancient grain, guaranteed under the KAMUT® brand, to never be hybridized or modified, always organically grown, prized for its nutrition, ease of digestibility, sweet nutty-buttery taste and firm texture, can be found throughout the world in products including breads, pasta, pizza, cereals, snacks, pastries, crackers, beer, green foods, and cereal drinks.

Media please contact Giselle Chollett: giselle@adinnyc.com, 917.386.7116.

###

(i) Pagliai G. et al. 2020. Effectiveness of a Khorasan Wheat-Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia. Pain Medicine. 21(10):2366-2372.

(ii)Baldi S. et al. 2022. Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia. World Journal of Gastroenterology. 28(18): 1965–80.

Share article on social media or email:

ClinicalMind

A diverse pipeline of talent and leadership is critical to the health of the biopharmaceutical industry, including ClinicalMind. For our part, making a long-term commitment to this scholarship fund is simply one small step to help create a stronger, more diverse future for our industry.

NEW YORK (PRWEB)
June 20, 2022

Medical Communications agency ClinicalMind has joined forces with the American Foundation for Pharmaceutical Education (AFPE) to create the annual ClinicalMind Scholarship for Black Pharmacy Students. This competitive scholarship will be awarded annually to two Black pharmacy students pursuing a PhD or PharmD and focusing their research on rare disease, gene therapy, small molecule therapeutics, or underserved populations.

Jeanne Martel, CEO of ClinicalMind, says, “It is very clear that a diverse pipeline of talent and leadership is critical to the health of the biopharmaceutical industry, including ClinicalMind. For our part, making a long-term commitment to this scholarship fund is simply one small step to help create a stronger, more diverse future for our industry.”

Much of the scientific content development and Medical Affairs talent pool for Life Sciences comes from the pharmacy education system. Today, leadership in biopharma includes relatively few Black voices. In 2014, only 2.3% of graduating pharmacy students were black, which increased to 9.3% in 2019. Martel adds, “We know that deeply rooted challenges and barriers have caused this disparity, but we are encouraged that leadership in organizations across the industry, including the AFPE, recognize this and are taking action.” Ellen Woods, president of the AFPE says, “We are pleased to partner with ClinicalMind in our effort to enhance opportunities for underrepresented minorities and promote important research.”

Applications for the 2022 scholarship are currently being accepted, and recipients will be announced before the end of the year.

ABOUT CLINICALMIND

ClinicalMind is a rapidly growing health-care communications company known for providing innovative technology solutions, outstanding scientific storytelling, and an exceptional client experience. ClinicalMind combines a diverse portfolio of capabilities into a seamlessly integrated set of solutions for biotechnology and pharmaceutical clients. For more information, visit: http://www.clinicalmind.com.

ABOUT THE AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE)

The AFPE supports the education of pharmaceutical scientists and strengthens pharmacy education at U.S. schools of pharmacy through scholarships and fellowships that provide recognition and financial support to outstanding pharmaceutical science graduate students, PharmD candidates, and pharmacy faculty researchers. AFPE uses annual tax-deductible contributions from corporations, foundations, associations, alumni, friends, and former Fellows to support the robust pharmaceutical education scholarship and fellowship programs.

Share article on social media or email: